✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Venmax Drugs And Pharmaceuticals Ltd.

VENMAX

Market Cap
₹12 Cr.
P/E
0.00

Venmax Drugs And Pharmaceuticals Ltd.

  • Venmax Drugs&Pharma
  • Unjha Formulations
  • Decipher Labs
FAQs on Venmax Drugs And Pharmaceuticals Ltd. Shareprice

Venmax Drugs&Pharma has given better returns compared to its competitors.
Venmax Drugs&Pharma has grown at ~34.16% over the last 6yrs while peers have grown at a median rate of 15.23%

There is insufficient historical data to gauge this.
Latest PE of Venmax Drugs&Pharma is 0

View FAQ's On Business
Growth Table
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Balance Sheet
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Cash Flow
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Quarterly Results
  • Venmax Drugs And Pharmaceuticals Ltd.
  • Unjha Formulations
  • Decipher Labs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Venmax Drugs And Pharmaceuticals Ltd. Financials

Venmax Drugs&Pharma balance sheet is weak and might have solvency issues

The net debt of Venmax Drugs&Pharma is decreasing.
Latest net debt of Venmax Drugs&Pharma is -₹2.43 Crs as of Mar-25.
This is less than Mar-24 when it was ₹0.35 Crs.

No, profit is decreasing.
The profit of Venmax Drugs&Pharma is ₹0.06 Crs for Mar 2024, ₹0.23 Crs for Mar 2023 and ₹1.85 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Venmax Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech